A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 39, 2006, Pages 14519-14524

  Yoshioka, Norie ^a   Wang, Li ^a,b   Kishimoto, Koji ^a,c   Tsuji, Takanori ^a   Hu, Guo Fu ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NORTHEAST NORMAL UNIVERSITY   (China)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

Nuclear translocation; Ribosome biogenesis; Tumor therapy

Indexed keywords

AGAR; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANGIOGENESIS INHIBITOR; ANGIOGENIN; ANTINEOPLASTIC AGENT; NEOMYCIN; PROTEIN KINASE B; RIBOSOME RNA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CARCINOMA IN SITU; CELL NUCLEUS; CELL PROLIFERATION; CELL STIMULATION; COLONY FORMATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE CARCINOMA; KNOCKOUT GENE; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RNA TRANSCRIPTION; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; CELL NUCLEUS; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, NUDE; NEOMYCIN; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; PROTEIN TRANSPORT; RIBONUCLEASE, PANCREATIC; RNA, RIBOSOMAL; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

MUS MUSCULUS;

EID: 33749251639     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0606708103     Document Type: Article

References (36)

1. Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallee BL (1985) Biochemistry 24:5480-5486.
2. Montero S, Guzman C, Cortes-Funes H, Colomer R (1998) Clin Cancer Res 4:2161-2168.
3. Chopra V, Dinh TV, Hannigan EV (1998) Cancer Invest 16:152-159.
4. Li D, Bell J, Brown A, Berry CL (1994) J Pathol 172:171-175.
5. Shimoyama S, Shimizu N, Tsuji E, Yamasaki K, Kawahara M, Kaminishi M (2002) Anticancer Res 22:1045-1052.
6. Chopra V, Dinh TV, Hannigan EV (1997) J Cancer Res Clin Oncol 123:167-172.
7. Shimoyama S, Kaminishi M (2000) J Cancer Res Clin Oncol 126:468-474.
8. Hisai H, Kato J, Kobune M, Murakami T, Miyanishi K, Takahashi M, Yoshizaki N, Takimoto R, Terui T, Niitsu Y (2003) Clin Cancer Res 9:4852-4859.
9. Wechsel HW, Bichler KH, Feil G, Loeser W, Lahme S, Petri E (1999) Anticancer Res 19:1537-1540.
10. Barton DP, Cai A, Wendt K, Young M, Gamero A, De Cesare S (1997) Clin Cancer Res 3:1579-1586.
11. Shimoyama S, Gansauge F, Gansauge S, Negri G, Oohara T, Beger HG (1996) Cancer Res 56:2703-2706.
12. Katona TM, Neubauer BL, Iversen PW, Zhang S, Baldridge LA, Cheng L (2005) Clin Cancer Res 11:8358-8363.
13. Miyake H, Kara I, Yamanaka K, Gohji K, Arakawa S, Kamidono S (1999) Cancer 86:316-324.
14. Eberle K, Oberpichler A, Trantakis C, Krupp W, Knupfer M, Tschesche H, Seifert V (2000) Anticancer Res 20:1679-1684.
15. Verstovsek S, Kantarjian H, Aguayo A, Manshouri T, Freireich E, Keating M, Estey E, Albitar M (2001) Br J Haematol 114:290-295.
16. Brunner B, Gunsilius E, Schumacher P, Zwierzina H, Gastl G, Stauder R (2002) J Hematother Stem Cell Res 11:119-125.
17. Bertolini F, Paolucci M, Peccatori F, Cinieri S, Agazzi A, Ferrucci PF, Cocorocchio E, Goldhirsch A, Martinelli G (1999) Br J Haematol 106:504-509.
18. Hartmann A, Kunz M, Kostlin S, Gillitzer R, Toksoy A, Brocker EB, Klein CE (1999) Cancer Res 59:1578-1583.
19. Kushlinskii NE, Babkina IV, Solov'ev YN, Trapeznikov NN (2000) Bull Exp Biol Med 130:691-693.
20. Skoldenberg EG, Christiansson J, Sandstedt B, Larsson A, Lackgren G, Christofferson R (2001) J Urol 165:2274-2279.
21. Majumder PK, Yeh JJ, George DJ, Febbo PG, Kum J, Xue Q, Bikoff R, Ma H, Kantoff PW, Golub TR, et al. (2003) Proc Natl Acad Sci USA 100:7841-7866.
22. Weiner HL, Weiner LH, Swain JL (1987) Science 237:280-282.
23. Olson KA, Byers HR, Key ME, Fett JW (2002) Int J Cancer 98:923-929.
24. Adams SA, Subramanian V (1999) Angiogenesis 3:189-199.
25. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI (2003) Nat Immunol 4:269-273.
26. Majumder PK, Febbo PG, Bikoff R, Berger R, Xue Q, McMahon LM, Manola J, Brugarolas J, McDonnell TJ, Golub TR, et al. (2004) Nat Med 10:594-601.
27. Campo L, Turley H, Han C, Pezzella F, Gatter KC, Harris AL, Fox SB (2005) J Pathol 205:585-591.
28. Tsuji T, Sun Y, Kishimoto K, Olson KA, Liu S, Hirukawa S, Hu GF (2005) Cancer Res 65:1352-1360.
29. Xu ZP, Tsuji T, Riordan JF, Hu GF (2003) Biochemistry 42:121-128.
30. Kishimoto K, Liu S, Tsuji T, Olson KA, Hu GF (2005) Oncogene 24:445-456.
31. Hu GF (1998) Proc Natl Acad Sci USA 95:9791-9795.
32. Kurachi K, Davie EW, Strydom DJ, Riordan JF, Vallee BL (1985) Biochemistry 24:5494-5499.
33. Olson KA, Byers HR, Key ME, Fett JW (2001) Clin Cancer Res 7:3598-3605.
34. Hirukawa S, Olson KA, Tsuji T, Hu GF (2005) Clin Cancer Res 11:8745-8752.
35. Hu G, Xu C, Riordan JF (2000) J Cell Biochem 76:452-462.
36. Fett JW, Olson KA, Rybak SM (1994) Biochemistry 33:5421-5427.